跳至主要内容
临床试验/NCT04167098
NCT04167098Unknown不适用

A Prospective Randomized Placebo-controlled Trial Comparing Platelet-rich Plasma and Corticosteroid Injection for Treatment of Trigger Finger

Töölö Hospital1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
117
试验地点
1
主要终点
Symptom resolution

研究概览

简要总结

Study purpose is to evaluate the effectiveness of Platelet-rich Plasma (PRP) injection in the treatment of trigger finger. We compare PRP to a corticosteroid (methylprednisolone) injection in a prospective randomized triple-blind placebo-controlled study.

Patients with clinically confirmed trigger finger are randomized (1:1:1 computer generated sequence with random block size) to three parallel groups and will receive an injection of either PRP, corticosteroid or placebo (0.9% saline) around the affected tendon sheath in a double-blind setting.

Baseline data is collected and is followed by a phone call at 1 month, and follow-up visits at 3, 6, 12 and 24 months after the intervention. Unveiling of the allocation is at 6 months post-intervention.

The primary outcome measures are:

  • Symptom resolution
  • Patient-Rated Wrist Evaluation

Secondary outcomes:

  • Quick-Disabilities of the Arm, Shoulder and Hand
  • Pain Visual Analogue Score
  • Global improvement (7-step Likert-scale)
  • Grip strength
  • Finger range of motion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 - 75
  • Symptom duration > 3 months

排除标准

  • Rheumatoid arthritis or other condition requiring continuous oral corticosteroids
  • Previous history of surgery or injection to the affected ray
  • Alcohol or drug abuse
  • Mental instability

结局指标

主要结局

Symptom resolution

时间窗: 24 months

4-step Likert (0 = no response; 1 = partial response, but not satisfactory, warranting further treatment; 2 = partial response, satisfactory, not warranting further treatment; 3 = complete resolution of symptoms and signs)

Patient-Rated Wrist Evaluation

时间窗: 24 months

The PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists two subscales: Pain and Function (0=best possible outcome, 10=worst possible outcome)

次要结局

  • Global improvement(24 months)
  • Quick-Disabilities of the Arm, Shoulder and Hand(24 months)
  • Grip strength(24 months)
  • Finger range of motion (ROM)(24 months)
  • Pain (Visual Analogue Scale)(24 months)

研究者

发起方
Töölö Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Samuli Aspinen

Principal investigator

Töölö Hospital

研究点 (1)

Loading locations...

相似试验